IPO

Vijaya Diagnostic Centre Limited IPO

Mainboard

Hospital & Healthcare Services

Listed On: Sep 14, 2021 at ₹ 540.0 (NSE)

₹ 14868 /28 Shares

Check Allotment

Price Summary

Last Closing

1,162.00 (118.83%)

52 Week High

1,249.95

52 Week Low

580.80

Last Update

25-Nov-2024 3:30 PM

IPO Details

01 Sep, 2021

Open Date

03 Sep, 2021

Close Date

09 Sep, 2021

Allotment Date

14 Sep, 2021

Listing Date

Issue Price

₹522-531 per equity share (Employee Discount - ₹52)

Face Value

₹1 Per Equity Share 

Listing at Group

BSE, NSE

Registrar

KFintech Private Limited

List Price

540.0 (NSE)

Listing Date

2021-09-14

Market Lot

28 Shares (₹14,868/-)

Lead Manager

Edelweiss Financial Services Ltd, ICICI Securities Limited, Kotak Mahindra Capital Company Limited

Issue Size

35,688,064 Eq Shares of ₹1 (aggregating up to ₹1,895.04 Cr)

#Offer for Sale: 35,688,064 Eq Shares of ₹1 (aggregating up to ₹1,895.04 Cr)

Retail Portion

35%

Subscription

4.54 times

IPO Docs

DRHP RHP

IPO Subscription Details

As onQIBNIIRetailEmployeeTotal
Shares Offered / Reserved71,07,61353,30,7101,24,38,3231,50,0002,50,26,646
Day 1 - 01-09-21 05:00 PM0.23 x0.010.46 x0.25 x0.30 x
Day 2 - 02-09-21 05:00 PM0.32 x0.050.74 x0.52 x0.48 x
Day 3 - 03-09-21 05:00 PM13.07 x1.331.10 x0.98 x4.54 x

Valuations

Earnings Per Share (EPS)

₹8.33/-

P/E Ratio

63.78

RoNW

23.14%

Net Asset Value (NAV) - As on 30.06.21

₹38.53

Company Financials All values are in ₹ Cr.

31-Mar-2131-Mar-2031-Mar-19
Assets540.94482.25406.43
Revenue388.59354.18302.94
Profit After Tax84.9162.5046.27

About The Company

Vijaya Diagnostic Centre is one of the fastest-growing diagnostic chains in Southern India. The company offers a one-stop solution for pathology and radiology testing services. The company offers around 740 routine tests, 870 specialized pathology tests, 220 basic tests, and 320 advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers.

Company's operational network consists of 80 diagnostic centers and 11 reference laboratories spread across 13 cities and towns in the states of Telangana, Andhra Pradesh, National Capital Region, and Kolkata. 96.2% of the revenue comes from Hyderabad, the rest of Telangana, and the Andhra Pradesh region. During the year ended March 31, 2021, the company conducted approximately 6.20 Mn pathology tests and 0.89 Mn radiology tests for approximately 2.63 Mn customers.

As of March 31, 2021, all Vijaya Diagnostic Centre laboratories hold National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditations, and three diagnostic centers hold Patient Safety & Quality of Care (NABH) accreditations.

Read More

- Peers Comparison

P/B RatioP/E RatioRoNWNet Worth
Vijaya Diagnostic Centre Limited13.7863.7823.14%388.59
Dr. Lal Pathlabs Limited26.1685.0330.78%1,632.60
Metropolis Healthcare Ltd19.6554.6435.95%1,010.03
Thyrocare Technologies Ltd14.8140.2936.76%507.05

IPO - Ratings

Arihant Capital Markets LtdSubscribe For Listing Gains
Axis CapitalNeutral
Capital MarketAvoid
HDFC Securities LimiteDNeutral
Hem SecuritiesSubscribe
JM Financial Institutional SecuritiesNeutral
Kotak SecuritiesNeutral
KR Choksey Securities LtdSubscribe
Marwadi Shares and Finance LimitedSubscribe
Reliance SecuritiesSubscribe
Religare Broking LimitedNeutral
Ventura Securities LimitedSubscribe

- Promoter(s)

Pre Issue Share Holding: 59.78%

Post Issue Share Holding: 54.78%


Company Promoter(s)

  1. Dr. S. Surendranath Reddy

IPO - Issue Objectives

  1. Achieve the benefits of share listing on the Stock Exchanges.
  2. To make an offer for sale (OFS) of 35,688,064 shares.

IPO - Anchor Investors

Vijaya Diagnostic Centre mobilises Rs 566.12 crore from anchor investors ahead of IPO

Marquee investors participated in anchor book included Government Pension Fund Global, Fidelity Investment Trust, Aberdeen, Abu Dhabi Investment Authority (ADIA), Kuwait Investment Authority (KIA), Pioneer Investment Fund, CLSA, Franklin Templeton MF, Bajaj Allianz Life Insurance, SBI Life Insurance, and Kotak Life Insurance.

Among domestic investors, SBI Mutual Fund, Axis Mutual Fund, Aditya Birla Mutual Fund, ICICI Prudential Mutual Fund, Nippon India Mutual Fund, Franklin Templeton Mutual Fund, Mirae Mutual Fund, Edelweiss MF and DSP Mutual Fund.

IPO - FAQs

Ans. Vijaya Diagnostic Centre Limited IPO is a Mainboard IPO. The issue is priced at ₹522-531 per equity share (Employee Discount - ₹52). The minimum order quantity is 28 Shares. The IPO opens on Sep 1, 2021, and closes on Sep 3, 2021. KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Vijaya Diagnostic Centre Limited IPO opens on Sep 1, 2021 and closes on Sep 3, 2021.

Ans. The size of Vijaya Diagnostic Centre Limited IPO is 35,688,064 Eq Shares of ₹1 (aggregating up to ₹1,895.04 Cr) #Offer for Sale: 35,688,064 Eq Shares of ₹1 (aggregating up to ₹1,895.04 Cr).

Ans. The IPO price band is set between ₹522-531 per equity share (Employee Discount - ₹52).

Ans. To apply for Vijaya Diagnostic Centre Limited IPO IPO, follow the steps given below:

  • - Open the IPO Ji App or Website
  • - Find Vijaya Diagnostic Centre Limited IPO in the List of IPOs
  • - Press "Apply" Button
  • - Select Your Demat Account
  • - Select Your Shares Quantity and Submit
  • - Track Your IPO Status

Ans. The share allotment date of Vijaya Diagnostic Centre Limited IPO is Sep 9, 2021.

Ans. The Vijaya Diagnostic Centre Limited IPO will be listed on Sep 14, 2021.

Ans. Follow the steps to check the allotment status for Vijaya Diagnostic Centre Limited IPO here.